Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Oct 2012 03:30 PM
RNS
Change of Advisers
10 Sep 2012 11:10 AM
RNS
Holding(s) in Company
03 Sep 2012 05:39 PM
RNS
Holding(s) in Company
23 Aug 2012 07:00 AM
RNS
Holding(s) in Company
20 Aug 2012 04:03 PM
RNS
Holding(s) in Company
20 Aug 2012 04:01 PM
RNS
Market Update
17 Aug 2012 09:24 AM
RNS
Holding(s) in Company
15 Aug 2012 01:12 PM
RNS
Moditope Vaccine Technology Platform
19 Jun 2012 07:00 AM
RNS
Long Term Treatment Approval
25 May 2012 07:00 AM
RNS
Vesting of Ichor Options
02 May 2012 07:00 AM
RNS
SCIB1 Update
17 Apr 2012 07:00 AM
RNS
SCIB1 Trial Update
16 Apr 2012 11:34 AM
RNS
Holding(s) in Company
13 Mar 2012 08:23 AM
RNS
Notice of Investor Meeting
09 Mar 2012 07:00 AM
RNS
Patent Approval
29 Feb 2012 03:49 PM
RNS
Change of Registered Office
31 Jan 2012 07:00 AM
RNS
Half Year Results
13 Dec 2011 04:28 PM
PRN
Issue of Equity
17 Nov 2011 11:29 AM
PRN
Holdings in Company
04 Nov 2011 07:00 AM
PRN
Confirmation of GBP2.85 million payment
25 Oct 2011 07:00 AM
PRN
Progress on possible GBP2.85m payment
20 Oct 2011 09:00 AM
PRN
SCIB 1 Patent Awarded
19 Aug 2011 12:25 PM
PRN
Holding(s) in Company
18 Aug 2011 11:37 AM
PRN
Appointment of Director
17 Aug 2011 07:00 AM
PRN
SCIB1: Safety Review and Dose Escalation
26 Jul 2011 01:01 PM
PRN
Holding(s) in Company
25 Jul 2011 12:45 PM
PRN
AGM & EGM Statement
30 Jun 2011 11:48 AM
PRN
Change of Board Structure
30 Jun 2011 11:46 AM
PRN
Development of new vaccine for treating lung ca...
30 Jun 2011 11:44 AM
PRN
Placing to raise £1.73 million
30 Jun 2011 11:37 AM
PRN
Final Results
03 Jun 2011 07:00 AM
PRN
Appointment of Broker
31 Jan 2011 08:30 AM
PRN
Interim Results
31 Jan 2011 07:00 AM
PRN
SCIB1: Safety Review and Dose Escalation
28 Jan 2011 07:00 AM
PRN
Re: SCIB1 Clinical Trial Patient Recruitment
13 Jan 2011 07:00 AM
PRN
Issue of Equity
14 Dec 2010 02:25 PM
PRN
Result of AGM
14 Dec 2010 07:00 AM
PRN
AGM Statement
07 Sep 2010 11:00 AM
PRN
Re: ImmuneRegen Strategic Collaboration
06 Sep 2010 07:00 AM
PRN
Appointment of Broker
10 Aug 2010 07:00 AM
PRN
Licence Agreement with Cancer Research Technology
14 Jul 2010 12:17 PM
PRN
Grant of Options
14 Jul 2010 09:46 AM
PRN
Admission to AIM
14 Jul 2010 09:37 AM
PRN
Final Results
29 Jun 2010 11:00 AM
PRN
Supply Agreement - Share Options
29 Jun 2010 07:00 AM
PRN
immatics Research Collaboration
15 Jun 2010 07:00 AM
PRN
SCIB1 Phase I Clinical Trial Commences
04 Jun 2010 07:00 AM
PRN
Strategic Collaboration - ImmuneRegen BioSciences
13 May 2010 09:43 AM
PRN
Replacement - NIH Licensing Agreeme
11 May 2010 07:00 AM
PRN
National Institutes of Health Licensing Agreement

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings